ENDEVICA BIO

Endevica Bio create best-in-class peptide drug candidates with better safety and efficacy properties than other drugs in the same class. Endevica’s technology platform, protected by a family of patents and pending applications, allows for the modification of peptides to perform with improved half-life, oral activity, and the ability to cross the blood-brain barrier.

#SimilarOrganizations #People #Financial #Website #More

ENDEVICA BIO

Social Links:

Linkedin

Industry:

Biotechnology Pharmaceutical Therapeutics

Founded:

2009-01-01

Address:

Columbia, Missouri, United States

Country:

United States

Website Url:

http://www.tcitherapeutics.com

Total Employee:

1+

Status:

Active

Contact:

(573) 881-5080

Email Addresses:

[email protected]

Total Funding:

4 M USD

Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

Current Employees Featured

not_available_image

Kenneth Gruber
Kenneth Gruber Founder, President & Chief Scientific Officer @ Endevica Bio
Founder, President & Chief Scientific Officer

not_available_image

Jake Halliday
Jake Halliday Chief Executive Officer @ Endevica Bio
Chief Executive Officer

Founder

not_available_image

Kenneth Gruber

Investors List

national-cancer-institute_image

National Cancer Institute

National Cancer Institute investment in Grant - Endevica Bio

centennial-investors_image

Centennial Investors

Centennial Investors investment in Series A - Endevica Bio

Official Site Inspections

http://www.tcitherapeutics.com

Host Informations
Whois Informations

Loading ...

More informations about "Endevica Bio" on Search Engine